References
- Pharmacologic basis of therapeutics, 4th ed, L S Goodman, A Oilman. Macmillan, New York 1970; 21
- Wilder-Smith C H, Halter F, Ernst T, et al. Loss of acid suppression during dosing with H,-receptor antagonists. Aliment Pharmacol Ther 1990; 4: 15–27, Suppl 1
- Wilder-Smith C H, Ernst T, Gennoni M, Zeyen B, Halter F, Merki H S. Tolerance to oral H2-receptor antagonists. Dig Dis Sci 1990; 8: 976–83
- Smith J TL, Gavey C, Nwokolo C U, Pounder R E. Tolerance during 8 days of high-dose H2-blockade. Aliment Pharmacol Ther 1990; 4: 47–63, Suppl 1
- Rogers M J, Holmfield J HM, Primrose J N, Johnston D. The effect of 15 days dosing with placebo, sufotidine 600 mg nocte or sufotidine 600 mg twice daily upon 24-hour intragastric acidity and 24-hour plasma gastrin. Aliment Pharmacol Ther 1990; 4: 65–74, Suppl 1
- Nwokolo C U, Smith J TL, Gavey C, Sawyerr A M, Pounder R E. Tolerance during 29 days of conventional dosing with cimetidine, nizatidine, famotidine or ranitidine. Aliment Pharmacol Ther 1990; 4: 29–45, Suppl 1
- Nwokolo C U, Prewett E J, Sawyerr A M, Hudson M, Lim S, Pounder R E. Tolerance during 5 months dosing with ranitidine 150 mg nightly: a placebo-controlled, double-blind study. Gastroenterology 1991; 101: 948–53
- Hyman P E, Garvey T Q, Abrams C E. Tolerance to intravenous ranitidine. J Pediatr 1987; 110: 794–6
- Ostro M J, Russel J A, Soldin S J, Mahon W A, Jeejeebhoy K N. Control of gastric pH with cimetidine: boluses versus primed infusions. Gastroenterology 1985; 89: 532–7
- Wilder-Smith C H, Halter F, Hacki W, Merki H S. pH-feedback controlled infusions of ranitidine are no more effective than fixed-dose infusions in reducing gastric acidity and variability in antisecretory responses. Br J Clin Pharmacol 1992; 33: 487–93
- Merki H S, Wilder-Smith C H, Walt R P, Hunt R, Renner E L, Halter F. Differential circadian effects and development of tolerance to an H2-receptor antagonist. Gastroenterology 1990; 98: A88
- Aadland E, Berstad A. Effect of cimetidine on pentagastrin-stimulated gastric acid and pepsin secretion before and after 6 weeks of cimetidine treatment. Scand J Gastroenterol 1978; 13: 193–7
- Sewing K F, Hagie L, Ippoliti A F, Isenberg J I, Samloff I M, Sturdevant R AL. Effect of one month treatment with cimetidine on gastric secretion and serum gastrin and pepsinogen levels. Gastroenterology 1978; 74: 376–9
- Barbezat G O, Bank S. Effect of prolonged cimetidine therapy on gastric acid secretion in man. Gut 1978; 19: 151–4
- Aadland E, Berstad A. Parietal and chief cell sensitivity to pentagastrin stimulation before and after cimetidine treatment for duodenal ulcer. Scand J Gastroenterol 1979; 14: 111–4
- Mohammed R, Holden R J, Hearns J B, McKibben B M, Buchanan I, Crean G P. Effect of 8 weeks continuous treatment with oral ranitidine and cimetidine on gastric acid secretion, pepsin secretion and fasting gastrin. Gut 1983; 24: 61–6
- Prichard P J, Jones D B, Yeomans N D, Mihaly G W, Smallwood R A, Louis W J. The effectiveness of ranitidine in reducing gastric acid secretion decreases with continued therapy. Br J Clin Pharmacol 1986; 22: 663–8
- Tytgat G N, Hameeteman W, Mulder C JJ, Wiersinga W, Van De Boomgaard D M, Dees J. Five-year cimetidine maintenance trial for peptic ulcer disease. Scand J Gastroenterol 1990; 25: 974–80
- Jones D B, Howden C W, Burget D W, Silletti C, Hunt R H. Alteration of H2-receptor sensitivity in duodenal ulcer patients after maintenance treatment with an H2-receptor antagonist. Gut 1988; 29: 890–3
- Wilder-Smith C H, Halter F, Merki H S. Tolerance and rebound to H2-receptor antagonists: intragastric acidity in patients with duodenal ulcer. Dig Dis Sci 1991; 36: 1685–90
- Burget D W, Chiverton S G, Hunt R H. Is there an optimal degree of acid suppression for healing of duodenal ulcer?. Gastroenterology 1990; 99: 345–51
- Jensen R T., Gardner J D, Raufman J P. Zollinger-Ellison syndrome: current concepts and management. Ann Intern Med 1983; 98: 59–75
- Ballesteros M A, Hogen D L, Koss M A, Isenberg J I. Bolus or intravenous infusion of ranitidine: effects on gastric pH and acid secretion. Ann Intern Med 1990; 112: 334–9
- Wilder-Smith C H, Merki H S. Antisecretory agents in stress ulcer prophylaxis: a critical reappraisal. Eur J Gastroenterol Hepatol 1992; 4: 689–95
- Bertaccini G, Coruzzi G. Regulation of receptors on parietal cells on acid secretion. Scand J Gastroenterol 1988; 23: 22–33, Suppl 146
- Soil A H. Review: Antisecretory drugs: cellular mechanisms of action. Aliment Pharmacol Ther 1987; 1: 77–89